Yali Friedman, author of Building Biotechnology, and Jeremy Abbate discuss the report at the Biotechnology Industry Organizationâs annual convention, providing a look at areas where innovation thrives and where it does not. They also discuss the impact of the global economic crisis on innovation.
Friedman is also managing editor of the Journal of Commercial Biotechnology and lead editorial consultant for Scientific American Worldview. Jeremy Abbate is the director of Global Media Solutions for Scientific American.
BIO represents more than 1,200 biotechnology companies, academic institutions and state biotechnology centers in the United States and 30 other nations.
To see Friedman and Abbate discussing the scorecard go to www.moreaboutthat.info, click on BIO Innovation and play or dow...
